Login

Kuvera interviews Rahul Singh, Chief Investment Officer - Equities at Tata Asset Management, about Multi Cap Funds.|Gaurav Rastogi is the CEO of Kuvera 00:10:00

Share On Facebook Share On Twitter

Gaurav Rastogi is the CEO of Kuvera

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Invests growth-stage capital in companies that have the potential for both excellent financial returns and sustainable|Edward Dugger III,President,Reinventure Capital
00:10:00
Canada's Geoscience Leadership: Shaping Tomorrow's Earth | Daniel Lebel - Director of Geological Survey of Canada
00:10:00
Boost Your Retirement Savings: Urgent Tips for Financial Security
00:10:00
The CEO Outlook highlights that dotdigital Group Plc, a UK-based company, provides software as a service (SaaS) solutions, focusing on omnichannel marketing automation and customer engagement platforms​ |Milan Patel, CEO of Dotdigital
00:10:00
Science Outreach category from Nature in partnership|Ananya Vasagiri, Analyst,Schematic Ventures
00:10:00
ITW Olivier Sonneville (DRH CS GROUP) et Marion Langlois (Elles Bougent) par Thomas Hugues | Pierre LOPEZ, Ceo, CS Group SASX:PAR
00:00:00
Bruce Walker, M.D., Professor of Medicine, HMS / The Need for an HIV Vaccine
00:10:00
Bart Verhaeghe: Proud That Club Brugge Can Compete with Europe's Best in UEFA Champions League | Bart Verhaeghe, CEO, Club Brugge KV.
00:10:00
"Robert F. Wallace on Managing Stanford's $35 Billion Investment Portfolio | Investment Conference 2024"
00:10:00
Richardson Electronics, Ltd. (NASDAQ: RELL) CEO Edward Richardson sat down with Proactive Investors at the 11th Annual LD Micro Main Event.
00:10:00
ASX CEO Connect: Adbri Limited (ASX: ABC) Spotlight | Mark Irwin - Chief Executive Officer of Adbri Ltd
00:10:00
Liberalism in Cold War Era: Evolving Ideals and Intellectual Debates|Samuel Moyn,Professor,Yale University

© 2026 Nehu